The Taco Bell Cyclospora MDL Petition Was Withdrawn — and Refiled for Michigan as MDL No. 3203

There is no Taco Bell cyclospora MDL, and the petition that was supposed to create one never reached argument: the Judicial Panel on Multidistrict Litigation set MDL No. 3196 for its 24 September 2026 session in Chicago, then entered an order deeming the motion withdrawn and vacating the hearing session order as to that docket and the 14 actions on its schedule. A second petition — MDL No. 3203, In re: 2026 Multistate Cyclosporiasis Outbreak Litigation (No. II), filed on 6 August 2026 — is now the live vehicle, and it asks for a different transferee court: the Eastern District of Michigan rather than the Northern District of California.

That substitution is the story. A withdrawn § 1407 motion is not a denial, carries no preclusive effect, and is one of the ordinary ways a centralization fight gets re-aimed before the Panel rules. What changed between the two petitions is not the defendants and not the outbreak — it is which half of this litigation the movants want centralized, and which district gets to run it.

Two petitions, one outbreak, and what happened to the first

The underlying facts are settled and, for a Mass Tort, unusually clean. The Centers for Disease Control and Prevention declared the 2026 multistate cyclosporiasis outbreak over on 11 September 2026, with a final count of 12,883 illnesses across 21 states, at least 570 hospitalizations, and two deaths, both in Michigan. Epidemiologic and traceback work by CDC and the Food and Drug Administration identified shredded iceberg lettuce grown and processed by Taylor Farms de Mexico — sourced from central Mexico, served at some Taco Bell restaurants and sold at retail — as the vehicle. On 17 July 2026, Taylor Farms de Mexico recalled all iceberg lettuce sourced from central Mexico.

The litigation split immediately into two streams, and the two JPML petitions track that split.

The first petition, docketed as MDL No. 3196, was filed in late July 2026. (Reported filing dates differ — HarrisMartin describes a 17 July motion, AboutLawsuits a 31 July filing, and the Panel's docket listing shows 1 August 2026; the public sources cannot be reconciled and are reported here as each stated them.) It sought transfer to the Northern District of California and identified three consumer protection class actions then pending in California, Michigan and Ohio. Those are economic-loss cases: the theory is that Taylor Farms and Taco Bell sold or served a contaminated product without warning purchasers, and that the purchase price is recoverable. The Panel set MDL No. 3196 for argument at the 24 September 2026 hearing session at the Northwestern Pritzker School of Law in Chicago, alongside the Amazon tariff-refund petition (MDL No. 3197), the NCAA age-based eligibility antitrust petition (MDL No. 3198) and the Apple AirTag petition (MDL No. 3199).

The second petition, MDL No. 3203, was filed on 6 August 2026 — before the Panel's hearing order issued, and well before the first petition came off the calendar. It is captioned as No. II because the Panel had already opened a docket number on the same subject matter, and it points at the Eastern District of Michigan. The moving brief, as reported by HarrisMartin, calls that court "the undisputed epicenter of the outbreak by a margin that cannot be ignored," and notes that Michigan ordinarily records approximately 40 to 50 cyclosporiasis cases in an entire year.

Both petitions name the same defendants. The difference is the inventory each is built on.

	MDL No. 3196	MDL No. 3203 (No. II)
Caption	In re: 2026 Multistate Cyclosporiasis Outbreak Litigation	In re: 2026 Multistate Cyclosporiasis Outbreak Litigation (No. II)
Filed	Late July 2026 (reported dates conflict)	6 August 2026
Transferee court sought	Northern District of California	Eastern District of Michigan
Core inventory	Three consumer protection class actions (CA, MI, OH)	Individual personal injury actions, Michigan-weighted
Claim type	Economic loss, Rule 23	Personal injury, product liability
Status	Motion deemed withdrawn; 24 September hearing session order vacated as to 14 actions	Pending before the Panel

Is there an MDL for the Taco Bell cyclospora lawsuits?

No. As of 20 September 2026 no Multidistrict Litigation (MDL) exists for the 2026 cyclosporiasis outbreak. MDL No. 3196 and MDL No. 3203 are Panel docket numbers assigned to motions to centralize, not to created MDLs; a docket number is opened when a § 1407 motion is filed, and it survives whether the Panel grants, denies, or never reaches the motion.

The distinction matters more than it sounds. Until the Judicial Panel on Multidistrict Litigation (JPML) enters a transfer order, every federal cyclosporiasis action stays with the judge it was assigned to — in the Eastern District of Michigan, the Northern District of Ohio, the Northern District of California and elsewhere — on that judge's schedule, with that judge's discovery rulings. There is no common transferee court, no leadership structure, no Plaintiff Fact Sheet (PFS), no Census Registry, and no Common Benefit Fund. Counsel coordinating an inventory are coordinating informally, case by case.

Named actions that have appeared on the Panel's schedules include Granados v. Taylor Fresh Foods, Inc. and Parrish v. Taco Bell Corp. The Parrish plaintiffs, Preston and Marie Parrish of Durand, Michigan, allege they ate food containing shredded iceberg lettuce at a Taco Bell in Shiawassee County on 30 June 2026. The first complaint of the outbreak was filed by Marler Clark against a Taco Bell operator in federal court in the Northern District of Ohio on behalf of a man who fell ill after eating at a restaurant in North Olmsted. By 11 August 2026, regional and legal press counted 14 federal suits against Taco Bell and Taylor Farms arising from the outbreak, with more expected; Ron Simon & Associates has said publicly that it represents hundreds of people sickened in this outbreak, and one firm told Michigan reporters it had more than 100 in-state clients whose cases had not all been filed.

Fourteen filed federal actions against a claimant pool of that size is the signature of an inventory in the tolling-and-negotiation phase, not a filed docket — which is precisely the condition in which the Panel's "how many actions are actually before us" question becomes hard.

Why was the cyclosporiasis MDL hearing on 24 September 2026 vacated?

Because the movants withdrew the motion. The Panel's order deeming the motion withdrawn and vacating the hearing session order as to MDL No. 3196 removed the matter and the 14 actions on its schedule from the 24 September calendar; the rest of that session — including the Apple AirTag and Amazon tariff petitions — proceeds as scheduled. No public order states a reason, and none is required: under the Panel's rules a movant may withdraw a § 1407 motion, and the Panel routinely disposes of the withdrawal administratively rather than by opinion.

What a withdrawal is not is a ruling. There is no adjudication of whether the cyclosporiasis actions share common questions of fact, no holding that centralization would or would not serve the convenience of parties and witnesses, and no bar on a later petition. The Panel did not decline to create a cyclosporiasis MDL; it was never asked to decide.

The reasonable inference from the sequence — a first petition built on three consumer class actions and aimed at California, withdrawn while a second petition built on the personal injury inventory and aimed at Michigan sat pending — is that the movants concluded the two petitions were competing for the same subject matter and that the stronger vehicle was the second one. Running both would have invited the Panel to do the tidying itself, and a Panel that tidies is a Panel deciding which inventory defines the litigation. There is no public filing confirming that reasoning, and it is offered as an inference from the docket sequence rather than as a reported fact.

Where would the cyclosporiasis MDL be centralized — California or Michigan?

On the live petition, Michigan. MDL No. 3203 asks for the Eastern District of Michigan; the California request died with MDL No. 3196.

The Panel's transferee-court analysis is not a beauty contest between districts, and the factors it actually uses line up unevenly here.

Factor	Eastern District of Michigan	Northern District of California
Where the claimants are	Michigan reported the largest share of illnesses of any state and both deaths	Few reported illnesses; the state is a filing venue, not an outbreak center
Where the evidence is	Restaurant-level records, state health department investigation files, treating providers, stool specimens	Taylor Farms' US corporate operations are California-based
Where the actions are	The personal injury inventory is Michigan-weighted	Held one of the three original consumer class actions
Convenience of witnesses	Claimants and treating physicians concentrated in-state	Corporate and traceback witnesses
Docket capacity	Not a high-volume MDL district; capacity is generally available	Already carries a heavy MDL and complex-litigation load

The Michigan argument is the one the Panel has historically found persuasive in single-outbreak food cases: put the litigation where the injured people, their medical records and the state investigation are. The California counter-argument — that the defendant's documents and corporate witnesses sit there — is the weaker of the two in an outbreak tort, because in these cases the contested discovery is rarely the supplier's document production. It is causation at the level of the individual claimant.

Whether the Panel reaches the question at all is a separate matter. The Panel denies centralization where the number of actions and involved courts is small enough that informal coordination is feasible, and fourteen federal actions across a handful of districts, with substantially overlapping plaintiffs' counsel, is squarely in the zone where that rationale has carried. The counterweight is trajectory: an outbreak with 12,883 confirmed illnesses and a claimant pool in the hundreds does not stay at fourteen filed cases.

The outbreak record the Panel will be handed

The evidentiary record here is stronger than in most food-borne mass torts, because the outbreak was large enough to generate real epidemiologic power and because the public health agencies published as they went.

Date	Event
Late June 2026	First illness onsets; Michigan clusters emerge
16–17 July 2026	Taylor Farms de Mexico withdraws and recalls all iceberg lettuce sourced from central Mexico
17 July 2026	CDC and FDA name shredded iceberg lettuce served at some Taco Bell locations as the source in five states — Indiana, Kentucky, Michigan, Ohio and West Virginia; first federal complaints filed
18 July 2026	FDA reports a Cyclospora-positive result on a Taylor Farms lettuce sample
19–20 July 2026	FDA re-reviews the result, calls it a false positive and removes it from the outbreak page
21 July 2026	FDA states that Taylor Farms lettuce remains the focus of the investigation notwithstanding the retraction
Late July 2026	§ 1407 motion docketed as MDL No. 3196; Northern District of California sought
6 August 2026	Second § 1407 motion filed, docketed as MDL No. 3203; Eastern District of Michigan sought
11 August 2026	Press counts 14 federal actions against Taco Bell and Taylor Farms
14 August 2026	Panel notices the 24 September 2026 hearing session, Chicago
11 September 2026	CDC declares the outbreak over: 12,883 illnesses, 21 states, at least 570 hospitalizations, two deaths
—	Panel enters order deeming the MDL No. 3196 motion withdrawn and vacating the hearing session order as to 14 actions

Two figures from the CDC record will do disproportionate work in any General Causation fight. The first is exposure prevalence: roughly 90 percent of interviewed patients reported eating iceberg lettuce, a rate far above background consumption and the kind of case-control signal that supports an epidemiologic attribution. The second is the epidemic curve's response to the recall. CDC reported that at the peak, before the 17 July recall, more than 1,000 infections occurred in a single day; by August the average had fallen below two per day. A curve that collapses within weeks of a single product's removal is the strongest circumstantial evidence a plaintiff can have that the product was the vehicle, and it is evidence no defense expert can re-run.

The defense record is not empty. CNN reported in August 2026 that Taylor Farms had been linked to five other Cyclospora or E. coli outbreaks over the preceding decade-plus — a fact that cuts against the company on notice and punitive exposure but also supplies an alternative-source argument in individual cases. Taylor Farms has said publicly that thousands of its product tests were negative. Yum! Brands told investors on its 30 July 2026 second-quarter call that Taco Bell sales were already improving, per CNBC, and a Taylor Farms executive was questioned by a member of Congress over the company's handling of the outbreak, per CBS News.

Two litigations, not one: class claims and personal injury claims

The single most consequential thing about the 2026 cyclosporiasis litigation is that it is two litigations with different claimants, different damages and different aggregation prospects — and the first MDL petition tried to centralize one of them while the second tries to centralize the other.

	Consumer class actions	Personal injury actions
Claimant	Anyone who bought or was served the product	Someone who contracted cyclosporiasis
Injury pleaded	Economic loss — the purchase price, benefit of the bargain	Illness, hospitalization, lost earnings, in two cases death
Theory	Consumer protection statutes, Failure to Warn, warranty	Negligence, strict product liability, Failure to Warn
Aggregation vehicle	Rule 23	MDL only; Class Certification is unavailable
Per-claim value	Nominal — single-digit to low double-digit dollars	Wide range, driven by hospitalization, duration and sequelae
Individual issues	Modest; purchase can be proved by records	Severe; diagnosis, exposure and alternative sources are all contested

Food-borne illness personal injury claims have never been certifiable as a Class Action for the same reason they resist a Settlement Matrix: Predominance fails when each claimant's diagnosis, treatment course, duration of illness and damages differ, and when causation must be proved person by person. Cyclosporiasis sharpens that. Its incubation period runs roughly a week, its symptoms — watery diarrhea, fatigue, weight loss, relapsing course — are indistinguishable from a dozen other causes without a laboratory finding, and the specific stool testing that identifies Cyclospora cayetanensis is not part of a routine gastrointestinal panel at many labs. A claimant who was sick for six weeks and never tested has a difficult case regardless of how strong the outbreak epidemiology is.

That is why the personal injury inventory, not the consumer class actions, is the part of this litigation that actually needs an MDL. The class claims are three cases with a common legal question and negligible individual discovery; they can be coordinated informally or consolidated in a single district by ordinary means. The personal injury claims are hundreds of files, each requiring a Plaintiff Fact Sheet-style workup, medical record collection, receipt or purchase evidence, and a Specific Causation showing — precisely the work a transferee judge exists to standardize.

Does the FDA's retracted lettuce test weaken the cyclospora lawsuits?

Less than the defense will argue, and more than plaintiffs would like. FDA reported a positive Cyclospora result on a Taylor Farms lettuce sample on 18 July 2026 and, within about 48 hours, re-reviewed it and withdrew it — stating that "due to the complexity in detection of Cyclospora, FDA laboratory experts re-reviewed the sample results and have concluded that the finding does not represent true amplification and should be considered a false positive." The agency removed the sample from its outbreak page and, on 21 July 2026, said Taylor Farms lettuce nonetheless remained the focus of the investigation.

What the retraction removes is a confirmatory product sample. What it leaves untouched is the structure of proof that actually carries a food-borne outbreak case: case-control exposure data, traceback to a common supplier and lot, the recall, and the epidemic curve's response to it. General Causation in these cases has never depended on isolating the organism from the food, and for Cyclospora it rarely can be — the parasite is notoriously difficult to detect in produce, which is exactly what FDA said in retracting the result. The retracted test was corroboration, not the spine.

The defense use is nonetheless real and will be made in every case. It is a Daubert Challenge argument in reverse: if the agency's own laboratory produced a false positive on the implicated product and had to withdraw it, a defense expert has a documented basis to attack the reliability of the identification chain and to argue that no contaminated product was ever found. It also supplies a jury narrative about regulatory error. Counsel on both sides should expect the retraction to appear in motions in limine long before it appears in front of a jury.

Product identification is the gating problem

In a supermarket recall, proving that a claimant consumed the recalled product is usually the hardest element. Here it splits.

For restaurant claimants, Product Identification is unusually tractable. A Taco Bell transaction produces a dated receipt, an app order history or a card record tying a named individual to a specific store on a specific day, and the distribution records tie that store to Taylor Farms lettuce in that window. Pair that with a stool-confirmed cyclosporiasis diagnosis within the incubation window and the causal chain is nearly documentary.

For retail claimants — people who bought bagged or shredded lettuce containing the same product — it is far harder. Shredded lettuce is bought without a durable record of the supplier, consumed over days, and rarely retained. Those claimants depend on loyalty-card purchase data, retailer distribution records, or nothing at all.

The practical consequence is a two-tier inventory. A transferee court, if one is appointed, will almost certainly be asked to sort it — through a fact sheet regime, a proof-of-purchase and proof-of-diagnosis requirement, and, if the untestable cases accumulate, something resembling a Lone Pine Order. Defendants have every incentive to push that sorting early; claimants' counsel have every incentive to push it late, after leverage has built. That fight is one of the first things the Michigan petition, if granted, will produce.

The Statute of Limitations adds a clock. Personal injury periods across the 21 affected states run from roughly one to six years, and the wrongful death claims in Michigan carry their own limits. Nothing about a pending § 1407 motion tolls anything, and the withdrawal of MDL No. 3196 tolled nothing either. Counsel holding unfiled inventory are holding it at their own risk.

What it means for claimants' counsel, defendants and the food bar

For claimants' counsel. The absence of an MDL is a cost, not a reprieve. Without a transferee court there is no common discovery of Taylor Farms' processing, testing and supplier-audit records, which means either duplicating that work in every case or waiting. Firms holding large unfiled inventories should be filing to preserve limitations and to build the action count the Panel will look at, and should be documenting purchase evidence and laboratory confirmation now, while receipts and specimens still exist. The realistic aggregation path runs through MDL No. 3203, and the case for it strengthens with every filed action.

For defendants. The withdrawal buys time and preserves the status quo, in which claims are handled individually and quietly. That position is durable only while the filed count stays low. Taylor Farms and Yum! Brands face a notice record — the prior-outbreak history CNN reported, and the company's own investor disclosures about produce-borne pathogen risk — that makes an early-and-quiet resolution strategy more attractive than a docket that eventually consolidates. Indemnity between supplier, franchisor and franchisee is its own litigation, and it is being fought without a coordinating judge.

For the food bar generally. This outbreak is the clearest recent demonstration that the aggregation architecture for food-borne illness is weaker than for pharmaceutical and device torts. There is no Rule 23 route for the injured, no established MDL for them to join, and a claimant pool an order of magnitude larger than the filed docket. The Panel's answer on MDL No. 3203 — whenever it comes, at the next available hearing session — will be read as a statement about whether a 12,883-illness outbreak is enough to move a food case into the MDL system at all.

Frequently asked questions

Is there an MDL for the Taco Bell cyclospora lawsuits?

No. No MDL has been created. MDL No. 3196 was a centralization motion that was deemed withdrawn, and MDL No. 3203 is a pending motion seeking the Eastern District of Michigan. Until the Panel enters a transfer order, each federal case stays in its own district.

How many people got sick in the 2026 cyclospora outbreak?

CDC's final count, published when it declared the outbreak over on 11 September 2026, was 12,883 illnesses in 21 states, with at least 570 hospitalizations and two deaths, both in Michigan. It is the largest cyclosporiasis outbreak recorded in the United States.

Who can file a Taco Bell cyclospora lawsuit?

Someone who ate the implicated shredded iceberg lettuce during the outbreak window and developed cyclosporiasis. The strongest claims pair a laboratory-confirmed diagnosis with dated proof of the meal or purchase — a receipt, an app order history or a card record. Family members of the two people who died may bring wrongful death claims under Michigan law.

What is the difference between the cyclospora class actions and the personal injury cases?

The class actions seek economic loss — the price of a contaminated product sold without warning — and are brought under Rule 23 on behalf of purchasers. The personal injury cases seek damages for illness, hospitalization and lost earnings, are brought individually, and cannot be certified as a class because causation and damages differ for each claimant.

Does the FDA's retracted positive test hurt the claims?

It removes corroboration, not the case. The attribution to Taylor Farms lettuce rests on case-control exposure data, traceback to a single supplier, the recall and the collapse of the epidemic curve after it. FDA said after the retraction that the lettuce remained the focus of its investigation. Expect the retraction to be litigated as a reliability attack rather than as a defense on the merits.

What happens next in the cyclosporiasis litigation?

MDL No. 3203 awaits briefing and argument at the Panel's next available hearing session; responses from Taylor Farms, Taco Bell and the franchisee defendants will show whether centralization is opposed outright or only as to venue. In the meantime, individual filings continue in Michigan, Ohio and elsewhere, and limitations periods run.